D. G. MacManus Et Al. , "The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions," 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , vol.14, Montreal, Canada, 2008
MacManus, D. G. Et Al. 2008. The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions. 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , (Montreal, Canada).
MacManus, D. G., Miller, D., Kappos, L., Gold, R., Havrdova, E., Limmroth, V., ... Polman, C.(2008). The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions . 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Canada
MacManus, David Et Al. "The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions," 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Canada, 2008
MacManus, David G. Et Al. "The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions." 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , Montreal, Canada, 2008
MacManus, D. G. Et Al. (2008) . "The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions." 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , Montreal, Canada.
@conferencepaper{conferencepaper, author={David G. MacManus Et Al. }, title={The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions}, congress name={13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis}, city={Montreal}, country={Canada}, year={2008}}